AME Add to watchlist
$230.10 4.26 (-1.82%)
After Hours: $230.10 +0.00 (+0.00%)
Last updated: Apr 15, 2026 22:51
52-Week Range
$230.10
$153.73 $230.10 $242.05

Fundamentals Overview

AMETEK, Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 35.8 PEG 4.74 P/B 4.97 P/S 7.12

Intrinsic value (DCF)

-17.9% downside vs price

Profitability

Net margin 20%

Risk (Beta)

1.04 — in line vol

Earnings & growth

EPS $6.43 Rev +5.6% Profit +7.3% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 58% confidence Risk: Moderate Volatility — Beta 1.04. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B+ · Sentiment improving (2 upgrades) · 3M vs S&P 500: +9%

Pressures (Sell):

DCF 17.9% downside vs price

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$52.71B
P/E (TTM)
35.81
EPS (TTM)
$6.43
Dividend Yield
0.28%
52-Week Range
$153.73 - $242.05
Volume vs Avg
N/A
Beta
1.04

About

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-p...
Sector: Industrials
Headquarters: US
Employees: 21,500
IPO Date: Jul 1984
Beta: 1.04 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 7, Equal Weight: 6, Hold: 1, Neutral: 4, Outperform: 6, Overweight: 5, Perform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $188.96; current price is $230.10. That’s a -17.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 35.81
DCF value (model) $188.96 (-17.9% vs price)
PEG (TTM) 4.74
P/B (TTM) 4.97
P/S (TTM) 7.12
P/FCF (TTM) 31.53
Liquidity & enterprise
Current Ratio (TTM) 1.06
Quick Ratio (TTM) 0.67
Cash Ratio (TTM) 0.16
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 20%
Gross margin (TTM) 36.28%
Operating margin (TTM) 26.05%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for AME.

Analyst Sentiment at a Glance

B+ Sentiment Improving
Buy 7Equal Weight 6Hold 1Neutral 4Outperform 6Overweight 5Perform 1
2 upgrades, 1 downgrade
Price Target Consensus
Current $230.10
Median $240.00
Consensus $242.58
Low consensus $215.00
High consensus $271.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Baird maintain Neutral Neutral 2026-03-30
BMO Capital maintain Outperform Outperform 2026-03-27
Morgan Stanley maintain Equal Weight Equal Weight 2026-03-12
DA Davidson maintain Buy Buy 2026-02-05
DA Davidson maintain Buy Buy 2026-02-04
Barclays maintain Equal Weight Equal Weight 2026-02-04
Keybanc maintain Overweight Overweight 2026-02-04
Oppenheimer downgrade Outperform Perform 2026-01-27
Morgan Stanley maintain Equal Weight Equal Weight 2026-01-12
Keybanc maintain Overweight Overweight 2026-01-07
Barclays maintain Equal Weight Equal Weight 2026-01-07
Keybanc maintain Overweight Overweight 2026-01-06
Mizuho maintain Outperform Outperform 2026-01-05
TD Cowen upgrade Hold Buy 2025-12-23
DA Davidson maintain Buy Buy 2025-12-08
Baird maintain Neutral Neutral 2025-11-03
Barclays maintain Equal Weight Equal Weight 2025-10-31
Keybanc maintain Overweight Overweight 2025-10-31
RBC Capital maintain Outperform Outperform 2025-10-31
Truist Securities maintain Buy Buy 2025-10-08
TD Cowen upgrade Sell Hold 2025-09-02
Morgan Stanley maintain Equal Weight Equal Weight 2025-08-08
Baird maintain Neutral Neutral 2025-08-04
RBC Capital maintain Outperform Outperform 2025-08-01
DA Davidson maintain Buy Buy 2025-08-01
Keybanc maintain Overweight Overweight 2025-08-01
Mizuho maintain Outperform Outperform 2025-08-01
RBC Capital maintain Outperform Outperform 2025-05-16
Baird maintain Neutral Neutral 2025-05-07
Truist Securities maintain Buy Buy 2025-05-05